MeSH term
Frequency | Condition_Probility | DNA, Complementary | 2 | 0.0 |
Female | 3 | 0.0 |
Humans | 16 | 0.0 |
Male | 4 | 0.0 |
Middle Aged | 3 | 0.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Animals | 10 | 0.0 |
*Apoptosis | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Cytosol/metabolism | 2 | 0.0 |
Ligands | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proteins/*metabolism | 3 | 0.0 |
Transfection | 5 | 0.0 |
CHO Cells | 2 | 0.0 |
Caspases/metabolism | 3 | 0.0 |
Hamsters | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Signal Transduction | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Apoptosis/*physiology | 3 | 0.0 |
Cattle | 2 | 0.0 |
Mice | 3 | 0.0 |
Mitochondria/*metabolism | 2 | 1.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Line | 5 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Apoptosis | 4 | 0.0 |
Cell Death | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
Mutation | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Proteins/chemistry/*metabolism | 2 | 2.0 |
Gene Expression | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
Adult | 2 | 0.0 |
Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*physiology | 2 | 0.0 |
Antibodies | 2 | 0.0 |
